Abstract
Background: Rhinocerebral mucormycosis is a rare, rapidly progressive and potentially lethal disease almost exclusively affecting immunocompromised hosts or patients with metabolic disorders, such as poorly controlled diabetes mellitus.
Methods: This work is aimed to describe five cases of rhinocerebral mucormycosis to review and possibly define diagnostic and surgical treatment guidelines. In all the patients, surgical debridement, systemic and local antifungal therapy, and oral rehabilitation using filling prostheses were performed. Results: None of the patients revealed recurrence of the infection, as confirmed by radiological and clinical long term follow up. Conclusion: Given the lethal nature of the disease, the authors underline the importance of early diagnosis and of a multidisciplinary approach in order to undertake correct surgical and medical treatments, while keeping the underlying disease under control.Keywords: Zygomycetes, Mucorales, rhinocerebral mucormycosis, immunocompromised patients, sinusitis, surgical debridement.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Rhinocerebral Mucormycosis with Orosinusal Involvement: Diagnostic and Surgical Treatment Guidelines
Volume: 16 Issue: 4
Author(s): Giuseppe Giudice, Daniela Anna Cutrignelli, Pasquale Sportelli, Luisa Limongelli, Angela Tempesta, Giuseppe Di Gioia, Luigi Santacroce, Eugenio Maiorano and Gianfranco Favia
Affiliation:
Keywords: Zygomycetes, Mucorales, rhinocerebral mucormycosis, immunocompromised patients, sinusitis, surgical debridement.
Abstract: Background: Rhinocerebral mucormycosis is a rare, rapidly progressive and potentially lethal disease almost exclusively affecting immunocompromised hosts or patients with metabolic disorders, such as poorly controlled diabetes mellitus.
Methods: This work is aimed to describe five cases of rhinocerebral mucormycosis to review and possibly define diagnostic and surgical treatment guidelines. In all the patients, surgical debridement, systemic and local antifungal therapy, and oral rehabilitation using filling prostheses were performed. Results: None of the patients revealed recurrence of the infection, as confirmed by radiological and clinical long term follow up. Conclusion: Given the lethal nature of the disease, the authors underline the importance of early diagnosis and of a multidisciplinary approach in order to undertake correct surgical and medical treatments, while keeping the underlying disease under control.Export Options
About this article
Cite this article as:
Giudice Giuseppe, Cutrignelli Anna Daniela, Sportelli Pasquale, Limongelli Luisa, Tempesta Angela, Gioia Di Giuseppe, Santacroce Luigi, Maiorano Eugenio and Favia Gianfranco, Rhinocerebral Mucormycosis with Orosinusal Involvement: Diagnostic and Surgical Treatment Guidelines, Endocrine, Metabolic & Immune Disorders - Drug Targets 2016; 16 (4) . https://dx.doi.org/10.2174/1871530316666161223145055
DOI https://dx.doi.org/10.2174/1871530316666161223145055 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot topic:Beta Cell Imaging - Why we need it and what has been Achieved (Executive Editor: Martin Gotthardt)]
Current Pharmaceutical Design Blood Pressure Lowering Treatment in Patients with Carotid Artery Stenosis
Current Hypertension Reviews Role of Vitamin D in the Pathophysiology and Treatment of Type 2 Diabetes
Current Diabetes Reviews The Atherosclerotic Plaque Vulnerability: Focus on the Oxidative and Endoplasmic Reticulum Stress in Orchestrating the Macrophage Apoptosis in the Formation of the Necrotic Core
Current Medicinal Chemistry Editorial (Thematic Issue: Endothelium: A Target for Therapeutic Intervention)
Current Vascular Pharmacology Update on Statins: Hope for Osteoporotic Fracture Healing Treatment
Current Drug Targets Statin Therapy-Evidence Beyond Lipid Lowering Contributing to Plaque Stability
Current Medicinal Chemistry Diabetes Mellitus Type 2 and Functional Foods of Plant Origin
Recent Patents on Biotechnology Patent Selections
Recent Patents on Biomarkers Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs
Current Pharmaceutical Design The Immune System in Space, Including Earth-Based Benefits of Space- Based Research
Current Pharmaceutical Biotechnology Do Adult Stem Cells Ameliorate the Damaged Myocardium? Human Cord Blood as a Potential Source of Stem Cells
Current Vascular Pharmacology Relationships Between White Matter Hyperintensities, Cerebral Amyloid Angiopathy and Dementia in a Population-based Sample of the Oldest Old
Current Alzheimer Research Peroxisome Proliferator Activated Receptor α Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism
Current Pharmaceutical Biotechnology Chickpea (Cicer arietinum L.) Lectin Exhibit Inhibition of ACE-I, α-amylase and α-glucosidase Activity
Protein & Peptide Letters Winning a Won Game: Caffeine Panacea for Obesity Syndemic
Current Neuropharmacology Effects of Moringa oleifera on Insulin Levels and Folliculogenesis in Polycystic Ovary Syndrome Model with Insulin Resistance
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pharmacological Management of Hypertension in the Elderly - Certitudes and Controversies
Current Pharmaceutical Design Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome
Current Pharmaceutical Design Neuropeptide/Receptor Expression and Plasticity in Micturition Pathways
Current Pharmaceutical Design